Stock Market

Wave Life Sciences Pipeline Review Boosts Stock Price Target

By Bullbit Editorial · March 30, 2026

WhatWave Life Sciences stock price target increased by Canaccord Genuity.
WhyAnalysts reviewed the company's pipeline, finding strong potential for growth.
SignalStrong pipeline review indicates a positive outlook for the company.
TargetCanaccord Genuity sets a new price target of $52 for Wave Life Sciences.
RiskInvestors should weigh the potential risks and rewards of investing in Wave Life Sciences.